AbbVie (ABBV) EBITDA Margin (2012 - 2026)
AbbVie's EBITDA Margin was 49.01% in Q2 2026, up 3.75 percentage points from 45.26% a year earlier and up 9.50 percentage points from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) EBITDA Margin (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, AbbVie's EBITDA Margin was 38.51% through Jun 30, 2026, up 5.37 percentage points year-over-year; for FY2025, it came in at 37.99%, up 6.89 percentage points from FY2024.
- EBITDA Margin shows a five-year change of -0.94 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was 31.11% in FY2024 (-8.39 pp), 39.50% in FY2023 (-6.31 pp), 45.81% in FY2022 (-1.25 pp) and 47.06% in FY2021 (+8.12 pp).
- The Q2 2026 figure marks the highest quarterly EBITDA Margin since Q2 2023.
- Compared with a year earlier, EBITDA Margin was higher in five of the last eight quarters, with an average year-over-year change of +0.35 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was Q4 2025 (a gain of 35.34 percentage points); the worst was Q4 2024 (a drop of 32.50 percentage points).
- Per Business Quant data, ABBV's EBITDA Margin in the three quarters before Q2 2026 was 39.50% (Q1 2026), 39.40% (Q4 2025) and 25.33% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 39.10% |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 7.35% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49.01% |
| Mar 31, 2026 | 39.50% |
| Dec 31, 2025 | 39.40% |
| Sep 30, 2025 | 25.33% |
| Jun 30, 2025 | 45.26% |
| Mar 31, 2025 | 43.57% |
| Dec 31, 2024 | 4.05% |
| Sep 30, 2024 | 40.95% |
| Jun 30, 2024 | 42.06% |
| Mar 31, 2024 | 39.65% |
| Dec 31, 2023 | 36.56% |
| Sep 30, 2023 | 32.15% |
| Jun 30, 2023 | 49.07% |
| Mar 31, 2023 | 40.04% |
| Dec 31, 2022 | 50.72% |
| Sep 30, 2022 | 45.80% |
| Jun 30, 2022 | 36.33% |
| Mar 31, 2022 | 50.34% |
| Dec 31, 2021 | 47.38% |
| Sep 30, 2021 | 44.83% |
API Access
AbbVie EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();